Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A.Kocher Technique: A Simplified Universally Applicable Approach for Aortic Root Enlargement.

Innovations (Philadelphia, Pa.)·2026
Same author

Organ transplantation in Fontan patients-beware of false promises.

JHLT open·2026
Same author

CT-Based Annular Dimensions in Transcatheter Mitral Valve Replacement: A Multicenter Registry Study.

The Annals of thoracic surgery·2026
Same author

The 10 Commandments for Oral Anticoagulation After Tissue Valve Replacement.

Innovations (Philadelphia, Pa.)·2026
Same author

Transcatheter Versus Minimally Invasive Surgical Aortic Valve Replacement With Rapid-Deployment Valves: A Propensity-Matched Analysis.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome.

PloS one·2026

Related Experiment Video

Updated: Jun 28, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Enhanced cell therapy for ischemic heart disease.

Nikolaos Bonaros1, Rauend Rauf, Thomas Schachner

  • 1Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Tyrol, Austria. nikolaos.bonaros@i-med.ac.at

Transplantation
|November 14, 2008
PubMed
Summary

Stem cell therapy shows promise for heart disease but faces challenges. Enhanced strategies like cell combination, genetic modification, and growth factors improve outcomes for regenerating heart tissue.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Stem cell therapy is a promising approach for treating degenerative heart disease.
  • Current limitations include poor cell survival, engraftment, and delivery methods.
  • Regenerating ischemic myocardium remains a significant clinical challenge.

Purpose of the Study:

  • To review strategies for enhancing stem cell therapy efficacy in ischemic heart disease.
  • To highlight methods for improving cell engraftment, survival, and functional outcomes.
  • To guide future research in optimizing cell delivery and therapeutic potential.

Main Methods:

  • Literature review of enhanced cell therapy approaches for cardiac regeneration.
  • Analysis of strategies including cell combination, genetic modification, and preconditioning.
  • Examination of growth factor administration, systemic therapy, and repetitive treatments.

Main Results:

  • Combination therapies (pre-co-cultured or co-injected cells) show improved results.
  • Genetically modified cells and controlled growth factor release enhance therapeutic effects.
  • Cell preconditioning, adjunctive systemic therapy, and repetitive treatments offer further benefits.

Conclusions:

  • Enhanced stem cell therapy strategies can overcome current limitations in treating ischemic heart disease.
  • Optimizing cell delivery, isolation, and functional outcomes is crucial for future advancements.
  • Further research is needed to fully realize the potential of stem cell therapy for cardiac repair.